Human RHD(Rh Blood Group, D Antigen) ELISA Kit

Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Rh Blood Group, D Antigen (RHD) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids.

Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Rh Blood Group, D Antigen (RHD) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids.

Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Rh Blood Group, D Antigen (RHD) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids.

Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Rh Blood Group, D Antigen (RHD) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids.

Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Human Rh Blood Group, D Antigen (RHD) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids with no significant corss-reactivity with analogues from other species.

Description: tissue homogenates, cell lysates and other biological fluids.

Description: tissue homogenates, cell lysates and other biological fluids.

Description: tissue homogenates, cell lysates and other biological fluids.

Description: tissue homogenates, cell lysates and other biological fluids.

Description: tissue homogenates, cell lysates or other biological fluids.

Description: tissue homogenates, cell lysates or other biological fluids.

Description: A competitive Inhibition ELISA kit for detection of Rh Blood Group, D Antigen from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids.

Description: Recombinant Human Rh Blood Group, D Antigen expressed in: chemical synthesis

Description: A Rabbit polyclonal antibody against Human Rh Blood Group, D Antigen (RHD)

Description: A Rabbit polyclonal antibody against Human Rh Blood Group, D Antigen (RHD). This antibody is labeled with PE.

Description: A Rabbit polyclonal antibody against Human Rh Blood Group, D Antigen (RHD). This antibody is labeled with APC.

Description: A Rabbit polyclonal antibody against Human Rh Blood Group, D Antigen (RHD). This antibody is labeled with Cy3.

Description: A Rabbit polyclonal antibody against Human Rh Blood Group, D Antigen (RHD). This antibody is labeled with HRP.

Description: A Rabbit polyclonal antibody against Human Rh Blood Group, D Antigen (RHD). This antibody is labeled with FITC.

Description: A Rabbit polyclonal antibody against Human Rh Blood Group, D Antigen (RHD). This antibody is labeled with Biotin.

Description: This is Competitive Enzyme-linked immunosorbent assay for Antibody Detection.detection of Human Anti-Rh Blood Group, D Antigen Antibody (Anti-RHD) in serum, plasma and other biological fluids.

Description: This is Competitive Enzyme-linked immunosorbent assay for Antibody Detection.detection of Human Anti-Rh Blood Group, D Antigen Antibody (Anti-RHD) in serum, plasma and other biological fluids.

Description: This is Competitive Enzyme-linked immunosorbent assay for Antibody Detection.detection of Human Anti-Rh Blood Group, D Antigen Antibody (Anti-RHD) in serum, plasma and other biological fluids.

Description: This is Competitive Enzyme-linked immunosorbent assay for Antibody Detection.detection of Human Anti-Rh Blood Group, D Antigen Antibody (Anti-RHD) in serum, plasma and other biological fluids.

Description: Enzyme-linked immunosorbent assay based on the Competitive Inhibition method for detection of Human Anti-Rh Blood Group, D Antigen Antibody (Anti-RHD) in samples from serum, plasma and other biological fluids with no significant corss-reactivity with analogues from other species.

Description: A Rabbit polyclonal antibody against Human Rh Blood Group, D Antigen (RHD). This antibody is labeled with APC-Cy7.

Description: A competitive Inhibition ELISA kit for detection of Anti-Rh Blood Group, D Antigen Antibody from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids.

Description: A sandwich ELISA for quantitative measurement of Human Blood group Rh(RHD) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: A sandwich ELISA for quantitative measurement of Human Blood group Rh(RHD) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: A sandwich ELISA for quantitative measurement of Human Blood group Rh(RHD) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: Quantitative sandwich ELISA for measuring Human Blood group Rh (RHD) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

Description: Quantitative sandwich ELISA for measuring Human Blood group Rh (RHD) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

Description: Quantitative sandwich ELISA for measuring Human Blood group Rh (RHD) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

Description: Recombinant Human Blood group Rh(D) polypeptide(RHD) expressed in in vitro E.coli expression system

Description: Recombinant Human Blood group Rh(D) polypeptide(RHD),partial expressed in E.coli

Description: Recombinant Human Blood group Rh(D) polypeptide(RHD),partial expressed in Mammalian cell

Description: A sandwich ELISA for quantitative measurement of Rat Blood group Rh(RHD) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: A sandwich ELISA for quantitative measurement of Rat Blood group Rh(RHD) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: A sandwich ELISA for quantitative measurement of Rat Blood group Rh(RHD) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: A sandwich ELISA for quantitative measurement of Canine Blood group Rh(RHD) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: A sandwich ELISA for quantitative measurement of Canine Blood group Rh(RHD) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: A sandwich ELISA for quantitative measurement of Canine Blood group Rh(RHD) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: A sandwich ELISA for quantitative measurement of Porcine Blood group Rh(RHD) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: A sandwich ELISA for quantitative measurement of Porcine Blood group Rh(RHD) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: A sandwich ELISA for quantitative measurement of Porcine Blood group Rh(RHD) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: A sandwich ELISA for quantitative measurement of Goat Blood group Rh(RHD) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: A sandwich ELISA for quantitative measurement of Goat Blood group Rh(RHD) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: A sandwich ELISA for quantitative measurement of Goat Blood group Rh(RHD) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: A sandwich ELISA for quantitative measurement of Mouse Blood group Rh(RHD) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: A sandwich ELISA for quantitative measurement of Mouse Blood group Rh(RHD) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: A sandwich ELISA for quantitative measurement of Mouse Blood group Rh(RHD) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: A sandwich ELISA for quantitative measurement of Rabbit Blood group Rh(RHD) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: A sandwich ELISA for quantitative measurement of Rabbit Blood group Rh(RHD) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: A sandwich ELISA for quantitative measurement of Rabbit Blood group Rh(RHD) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: A sandwich ELISA for quantitative measurement of Monkey Blood group Rh(RHD) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: A sandwich ELISA for quantitative measurement of Monkey Blood group Rh(RHD) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: A sandwich ELISA for quantitative measurement of Monkey Blood group Rh(RHD) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: A sandwich ELISA for quantitative measurement of Guinea pig Blood group Rh(RHD) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: A sandwich ELISA for quantitative measurement of Guinea pig Blood group Rh(RHD) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: A sandwich ELISA for quantitative measurement of Guinea pig Blood group Rh(RHD) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: anti-B human blood group antigen IgM

Description: anti-B human blood group antigen IgM

Description: anti-B human blood group antigen IgM

Description: Quantitative sandwich ELISA for measuring Human Blood group antigen-binding adhesin A (Bab A) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

Description: Quantitative sandwich ELISA for measuring Human Blood group antigen-binding adhesin A (Bab A) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

Description: Quantitative sandwich ELISA for measuring Human Blood group antigen-binding adhesin A (Bab A) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

Description: Mouse monoclonal Blood Group H ab Antigen antibody

Description: This antibody recognizes human blood group A (monofucosyl and difucosyl A antigens with chain types 1, 2, 3, 4, 5, 6) and Forssmann antigen. It is also reactive with the immuno-dominant A trisaccharide. Blood group antigen expression in human colon cancer was studied by means of two monoclonal antibodies of broad anti-A (HE-14) and anti-type 3 and type 4 chain-based A and H (HE-10) specificity. These antigens were proved to re-appear in tumors of the distal colon, the HE-10 antibody reacting more frequently (9 out of 12 samples) than HE-14 (5 out of 12 samples) and frequently with supra-nuclear staining of the cytoplasm probably in those places of the Golgi apparatus where carbohydrate antigens are synthesized. This staining pattern is characteristic of HE-10 in normal colonic mucosa as well. With HE-14, staining was often absent in less differentiated tumors, while HE-10 did react in such tumors. In some cases, these two antibodies gave different staining patterns in parallel sections from the same tissue sample, primarily at the cellular level. Three out of 12 cases showed blood group antigen expression in the mucosa of the distal colon adjacent to the tumor only when HE-10 mAb was used.

Description: This antibody recognizes human blood group A (monofucosyl and difucosyl A antigens with chain types 1, 2, 3, 4, 5, 6) and Forssmann antigen. It is also reactive with the immuno-dominant A trisaccharide. Blood group antigen expression in human colon cancer was studied by means of two monoclonal antibodies of broad anti-A (HE-14) and anti-type 3 and type 4 chain-based A and H (HE-10) specificity. These antigens were proved to re-appear in tumors of the distal colon, the HE-10 antibody reacting more frequently (9 out of 12 samples) than HE-14 (5 out of 12 samples) and frequently with supra-nuclear staining of the cytoplasm probably in those places of the Golgi apparatus where carbohydrate antigens are synthesized. This staining pattern is characteristic of HE-10 in normal colonic mucosa as well. With HE-14, staining was often absent in less differentiated tumors, while HE-10 did react in such tumors. In some cases, these two antibodies gave different staining patterns in parallel sections from the same tissue sample, primarily at the cellular level. Three out of 12 cases showed blood group antigen expression in the mucosa of the distal colon adjacent to the tumor only when HE-10 mAb was used.

Description: This antibody recognizes human blood group A (monofucosyl and difucosyl A antigens with chain types 1, 2, 3, 4, 5, 6) and Forssmann antigen. It is also reactive with the immuno-dominant A trisaccharide. Blood group antigen expression in human colon cancer was studied by means of two monoclonal antibodies of broad anti-A (HE-14) and anti-type 3 and type 4 chain-based A and H (HE-10) specificity. These antigens were proved to re-appear in tumors of the distal colon, the HE-10 antibody reacting more frequently (9 out of 12 samples) than HE-14 (5 out of 12 samples) and frequently with supra-nuclear staining of the cytoplasm probably in those places of the Golgi apparatus where carbohydrate antigens are synthesized. This staining pattern is characteristic of HE-10 in normal colonic mucosa as well. With HE-14, staining was often absent in less differentiated tumors, while HE-10 did react in such tumors. In some cases, these two antibodies gave different staining patterns in parallel sections from the same tissue sample, primarily at the cellular level. Three out of 12 cases showed blood group antigen expression in the mucosa of the distal colon adjacent to the tumor only when HE-10 mAb was used.

Description: This antibody recognizes human blood group A (monofucosyl and difucosyl A antigens with chain types 1, 2, 3, 4, 5, 6) and Forssmann antigen. Blood-group antigens are generally defined as molecules formed by sequential addition of saccharides to the carbohydrate side chains of lipids and proteins detected on erythrocytes and certain epithelial cells. The A, B and H antigens are reported to undergo modulation during malignant cellular transformation. Blood group related antigens represent a group of carbohydrate determinants carried on both glycolipids and glycoproteins. They are usually mucin-type, and are detected on erythrocytes, certain epithelial cells, and in secretions of certain individuals. Sixteen genetically and biosynthetically distinct but inter-related specificities belong to this group of antigens, including A, B, H, Lewis A, Lewis B, Lewis X, Lewis Y, and precursor type 1 chain antigens.

Description: This antibody recognizes human blood group A (monofucosyl and difucosyl A antigens with chain types 1, 2, 3, 4, 5, 6) and Forssmann antigen. Blood-group antigens are generally defined as molecules formed by sequential addition of saccharides to the carbohydrate side chains of lipids and proteins detected on erythrocytes and certain epithelial cells. The A, B and H antigens are reported to undergo modulation during malignant cellular transformation. Blood group related antigens represent a group of carbohydrate determinants carried on both glycolipids and glycoproteins. They are usually mucin-type, and are detected on erythrocytes, certain epithelial cells, and in secretions of certain individuals. Sixteen genetically and biosynthetically distinct but inter-related specificities belong to this group of antigens, including A, B, H, Lewis A, Lewis B, Lewis X, Lewis Y, and precursor type 1 chain antigens.

Description: This antibody recognizes human blood group A (monofucosyl and difucosyl A antigens with chain types 1, 2, 3, 4, 5, 6) and Forssmann antigen. Blood-group antigens are generally defined as molecules formed by sequential addition of saccharides to the carbohydrate side chains of lipids and proteins detected on erythrocytes and certain epithelial cells. The A, B and H antigens are reported to undergo modulation during malignant cellular transformation. Blood group related antigens represent a group of carbohydrate determinants carried on both glycolipids and glycoproteins. They are usually mucin-type, and are detected on erythrocytes, certain epithelial cells, and in secretions of certain individuals. Sixteen genetically and biosynthetically distinct but inter-related specificities belong to this group of antigens, including A, B, H, Lewis A, Lewis B, Lewis X, Lewis Y, and precursor type 1 chain antigens.

Description: The antibody HEB-29 reacts with human blood group B. The specificity of the antibody HEB-29 was confirmed by comparison of specificity and reactivity to standard reagent using >5.000 samples of blood. mAb HEB-29 shows specific staining of erythrocytes and vascular epithelium of blood group B controls and no staining in group A controls. It is applicable for tissue staining in tumor patients with blood groups B and AB. Blood group antigens are generally defined as molecules formed by sequential addition of saccharides to the carbohydrate side chains of lipids and proteins detected on erythrocytes and certain epithelial cells. The A, B and H antigens are reported to undergo modulation during malignant cellular transformation. Blood group related antigens represent a group of carbohydrate determinants carried on both glycolipids and glycoproteins. They are usually mucin type, and are detected on erythrocytes, certain epithelial cells, and in secretions of certain individuals. Sixteen genetically and biosynthetically distinct but inter related specificities belong to this group of antigens, including A, B, H, Lewis A, Lewis B, Lewis X, Lewis Y, and precursor type 1 chain antigens.

Description: The antibody HEB-29 reacts with human blood group B. The specificity of the antibody HEB-29 was confirmed by comparison of specificity and reactivity to standard reagent using >5.000 samples of blood. mAb HEB-29 shows specific staining of erythrocytes and vascular epithelium of blood group B controls and no staining in group A controls. It is applicable for tissue staining in tumor patients with blood groups B and AB. Blood group antigens are generally defined as molecules formed by sequential addition of saccharides to the carbohydrate side chains of lipids and proteins detected on erythrocytes and certain epithelial cells. The A, B and H antigens are reported to undergo modulation during malignant cellular transformation. Blood group related antigens represent a group of carbohydrate determinants carried on both glycolipids and glycoproteins. They are usually mucin type, and are detected on erythrocytes, certain epithelial cells, and in secretions of certain individuals. Sixteen genetically and biosynthetically distinct but inter related specificities belong to this group of antigens, including A, B, H, Lewis A, Lewis B, Lewis X, Lewis Y, and precursor type 1 chain antigens.

Description: The antibody HEB-29 reacts with human blood group B. The specificity of the antibody HEB-29 was confirmed by comparison of specificity and reactivity to standard reagent using >5.000 samples of blood. mAb HEB-29 shows specific staining of erythrocytes and vascular epithelium of blood group B controls and no staining in group A controls. It is applicable for tissue staining in tumor patients with blood groups B and AB. Blood group antigens are generally defined as molecules formed by sequential addition of saccharides to the carbohydrate side chains of lipids and proteins detected on erythrocytes and certain epithelial cells. The A, B and H antigens are reported to undergo modulation during malignant cellular transformation. Blood group related antigens represent a group of carbohydrate determinants carried on both glycolipids and glycoproteins. They are usually mucin type, and are detected on erythrocytes, certain epithelial cells, and in secretions of certain individuals. Sixteen genetically and biosynthetically distinct but inter related specificities belong to this group of antigens, including A, B, H, Lewis A, Lewis B, Lewis X, Lewis Y, and precursor type 1 chain antigens.

Description: The antibody HEB-20 reacts with human blood group B. The specificity of the antibody HEB-20 was confirmed by comparison of specificity and reactivity to standard reagent using >5.000 samples of blood. The mAb HEB-20 shows specific staining of erythrocytes and vascular epithelium of blood group B controls and no staining in group A controls. This mAb is applicable for tissue staining in tumor patients with blood groups B and AB. Blood group antigens are generally defined as molecules formed by sequential addition of saccharides to the carbohydrate side chains of lipids and proteins detected on erythrocytes and certain epithelial cells. The A, B and H antigens are reported to undergo modulation during malignant cellular transformation. Blood group related antigens represent a group of carbohydrate determinants carried on both glycolipids and glycoproteins. They are usually mucin type, and are detected on erythrocytes, certain epithelial cells, and in secretions of certain individuals. Sixteen genetically and biosynthetically distinct but inter related specificities belong to this group of antigens, including A, B, H, Lewis A, Lewis B, Lewis X, Lewis Y, and precursor type 1 chain antigens.

Description: The antibody HEB-20 reacts with human blood group B. The specificity of the antibody HEB-20 was confirmed by comparison of specificity and reactivity to standard reagent using >5.000 samples of blood. The mAb HEB-20 shows specific staining of erythrocytes and vascular epithelium of blood group B controls and no staining in group A controls. This mAb is applicable for tissue staining in tumor patients with blood groups B and AB. Blood group antigens are generally defined as molecules formed by sequential addition of saccharides to the carbohydrate side chains of lipids and proteins detected on erythrocytes and certain epithelial cells. The A, B and H antigens are reported to undergo modulation during malignant cellular transformation. Blood group related antigens represent a group of carbohydrate determinants carried on both glycolipids and glycoproteins. They are usually mucin type, and are detected on erythrocytes, certain epithelial cells, and in secretions of certain individuals. Sixteen genetically and biosynthetically distinct but inter related specificities belong to this group of antigens, including A, B, H, Lewis A, Lewis B, Lewis X, Lewis Y, and precursor type 1 chain antigens.

Description: The antibody HEB-20 reacts with human blood group B. The specificity of the antibody HEB-20 was confirmed by comparison of specificity and reactivity to standard reagent using >5.000 samples of blood. The mAb HEB-20 shows specific staining of erythrocytes and vascular epithelium of blood group B controls and no staining in group A controls. This mAb is applicable for tissue staining in tumor patients with blood groups B and AB. Blood group antigens are generally defined as molecules formed by sequential addition of saccharides to the carbohydrate side chains of lipids and proteins detected on erythrocytes and certain epithelial cells. The A, B and H antigens are reported to undergo modulation during malignant cellular transformation. Blood group related antigens represent a group of carbohydrate determinants carried on both glycolipids and glycoproteins. They are usually mucin type, and are detected on erythrocytes, certain epithelial cells, and in secretions of certain individuals. Sixteen genetically and biosynthetically distinct but inter related specificities belong to this group of antigens, including A, B, H, Lewis A, Lewis B, Lewis X, Lewis Y, and precursor type 1 chain antigens.

Description: The antibody HEB-20 reacts with human blood group B. The specificity of the antibody HEB-20 was confirmed by comparison of specificity and reactivity to standard reagent using >5.000 samples of blood. The mAb HEB-20 shows specific staining of erythrocytes and vascular epithelium of blood group B controls and no staining in group A controls. This mAb is applicable for tissue staining in tumor patients with blood groups B and AB. Blood group antigens are generally defined as molecules formed by sequential addition of saccharides to the carbohydrate side chains of lipids and proteins detected on erythrocytes and certain epithelial cells. The A, B and H antigens are reported to undergo modulation during malignant cellular transformation. Blood group related antigens represent a group of carbohydrate determinants carried on both glycolipids and glycoproteins. They are usually mucin type, and are detected on erythrocytes, certain epithelial cells, and in secretions of certain individuals. Sixteen genetically and biosynthetically distinct but inter related specificities belong to this group of antigens, including A, B, H, Lewis A, Lewis B, Lewis X, Lewis Y, and precursor type 1 chain antigens.

Description: This mAb preferably reacts with determinants of chain A and H type 3 (Gal1-3GalNAc-R) and 4 (Gal1-3GalNAc-R), but not with type 1 and 2 chain structures. It is not reactive with immuno-dominant A trisaccharide. This mAb is applicable for tissue staining in tumor patients with blood groups A and AB. It shows a highly heterogeneous reactivity in human colon tumor tissue and adjacent mucosa. Blood-group antigens are generally defined as molecules formed by sequential addition of saccharides to the carbohydrate side chains of lipids and proteins detected on erythrocytes and certain epithelial cells. The A, B and H antigens are reported to undergo modulation during malignant cellular transformation. Blood group related antigens represent a group of carbohydrate determinants carried on both glycolipids and glycoproteins. They are usually mucin-type, and are detected on erythrocytes, certain epithelial cells, and in secretions of certain individuals. Sixteen genetically and biosynthetically distinct but inter-related specificities belong to this group of antigens, including A, B, H, Lewis A, Lewis B, Lewis X, Lewis Y, and precursor type 1 chain antigens.

Description: This mAb preferably reacts with determinants of chain A and H type 3 (Gal1-3GalNAc-R) and 4 (Gal1-3GalNAc-R), but not with type 1 and 2 chain structures. It is not reactive with immuno-dominant A trisaccharide. This mAb is applicable for tissue staining in tumor patients with blood groups A and AB. It shows a highly heterogeneous reactivity in human colon tumor tissue and adjacent mucosa. Blood-group antigens are generally defined as molecules formed by sequential addition of saccharides to the carbohydrate side chains of lipids and proteins detected on erythrocytes and certain epithelial cells. The A, B and H antigens are reported to undergo modulation during malignant cellular transformation. Blood group related antigens represent a group of carbohydrate determinants carried on both glycolipids and glycoproteins. They are usually mucin-type, and are detected on erythrocytes, certain epithelial cells, and in secretions of certain individuals. Sixteen genetically and biosynthetically distinct but inter-related specificities belong to this group of antigens, including A, B, H, Lewis A, Lewis B, Lewis X, Lewis Y, and precursor type 1 chain antigens.

Description: This mAb preferably reacts with determinants of chain A and H type 3 (Gal1-3GalNAc-R) and 4 (Gal1-3GalNAc-R), but not with type 1 and 2 chain structures. It is not reactive with immuno-dominant A trisaccharide. This mAb is applicable for tissue staining in tumor patients with blood groups A and AB. It shows a highly heterogeneous reactivity in human colon tumor tissue and adjacent mucosa. Blood-group antigens are generally defined as molecules formed by sequential addition of saccharides to the carbohydrate side chains of lipids and proteins detected on erythrocytes and certain epithelial cells. The A, B and H antigens are reported to undergo modulation during malignant cellular transformation. Blood group related antigens represent a group of carbohydrate determinants carried on both glycolipids and glycoproteins. They are usually mucin-type, and are detected on erythrocytes, certain epithelial cells, and in secretions of certain individuals. Sixteen genetically and biosynthetically distinct but inter-related specificities belong to this group of antigens, including A, B, H, Lewis A, Lewis B, Lewis X, Lewis Y, and precursor type 1 chain antigens.

Description: This mAb preferably reacts with determinants of chain A and H type 3 (Gal1-3GalNAc-R) and 4 (Gal1-3GalNAc-R), but not with type 1 and 2 chain structures. It is not reactive with immuno-dominant A trisaccharide. This mAb is applicable for tissue staining in tumor patients with blood groups A and AB. It shows a highly heterogeneous reactivity in human colon tumor tissue and adjacent mucosa. Blood-group antigens are generally defined as molecules formed by sequential addition of saccharides to the carbohydrate side chains of lipids and proteins detected on erythrocytes and certain epithelial cells. The A, B and H antigens are reported to undergo modulation during malignant cellular transformation. Blood group related antigens represent a group of carbohydrate determinants carried on both glycolipids and glycoproteins. They are usually mucin-type, and are detected on erythrocytes, certain epithelial cells, and in secretions of certain individuals. Sixteen genetically and biosynthetically distinct but inter-related specificities belong to this group of antigens, including A, B, H, Lewis A, Lewis B, Lewis X, Lewis Y, and precursor type 1 chain antigens.

Description: This mAb preferably reacts with determinants of chain A and H type 3 (Gal1-3GalNAc-R) and 4 (Gal1-3GalNAc-R), but not with type 1 and 2 chain structures. It is not reactive with immuno-dominant A trisaccharide. This mAb is applicable for tissue staining in tumor patients with blood groups A and AB. It shows a highly heterogeneous reactivity in human colon tumor tissue and adjacent mucosa. Blood-group antigens are generally defined as molecules formed by sequential addition of saccharides to the carbohydrate side chains of lipids and proteins detected on erythrocytes and certain epithelial cells. The A, B and H antigens are reported to undergo modulation during malignant cellular transformation. Blood group related antigens represent a group of carbohydrate determinants carried on both glycolipids and glycoproteins. They are usually mucin-type, and are detected on erythrocytes, certain epithelial cells, and in secretions of certain individuals. Sixteen genetically and biosynthetically distinct but inter-related specificities belong to this group of antigens, including A, B, H, Lewis A, Lewis B, Lewis X, Lewis Y, and precursor type 1 chain antigens.

Description: This mAb preferably reacts with determinants of chain A and H type 3 (Gal1-3GalNAc-R) and 4 (Gal1-3GalNAc-R), but not with type 1 and 2 chain structures. It is not reactive with immuno-dominant A trisaccharide. This mAb is applicable for tissue staining in tumor patients with blood groups A and AB. It shows a highly heterogeneous reactivity in human colon tumor tissue and adjacent mucosa. Blood-group antigens are generally defined as molecules formed by sequential addition of saccharides to the carbohydrate side chains of lipids and proteins detected on erythrocytes and certain epithelial cells. The A, B and H antigens are reported to undergo modulation during malignant cellular transformation. Blood group related antigens represent a group of carbohydrate determinants carried on both glycolipids and glycoproteins. They are usually mucin-type, and are detected on erythrocytes, certain epithelial cells, and in secretions of certain individuals. Sixteen genetically and biosynthetically distinct but inter-related specificities belong to this group of antigens, including A, B, H, Lewis A, Lewis B, Lewis X, Lewis Y, and precursor type 1 chain antigens.

Description: This mAb preferably reacts with determinants of chain A and H type 3 (Gal1-3GalNAc-R) and 4 (Gal1-3GalNAc-R), but not with type 1 and 2 chain structures. It is not reactive with immuno-dominant A trisaccharide. This mAb is applicable for tissue staining in tumor patients with blood groups A and AB. It shows a highly heterogeneous reactivity in human colon tumor tissue and adjacent mucosa. Blood-group antigens are generally defined as molecules formed by sequential addition of saccharides to the carbohydrate side chains of lipids and proteins detected on erythrocytes and certain epithelial cells. The A, B and H antigens are reported to undergo modulation during malignant cellular transformation. Blood group related antigens represent a group of carbohydrate determinants carried on both glycolipids and glycoproteins. They are usually mucin-type, and are detected on erythrocytes, certain epithelial cells, and in secretions of certain individuals. Sixteen genetically and biosynthetically distinct but inter-related specificities belong to this group of antigens, including A, B, H, Lewis A, Lewis B, Lewis X, Lewis Y, and precursor type 1 chain antigens.

Description: Primary antibody against Blood group antigen B(HEB-29), CF594 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood group antigen B(HEB-29), CF594 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood group antigen B(HEB-29), CF680 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood group antigen B(HEB-29), CF680 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood group antigen B(HEB-29), CF680R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood group antigen B(HEB-29), CF680R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood group antigen B(HEB-29), CF770 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood group antigen B(HEB-29), CF770 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood group antigen B(HEB-29), CF488A conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood group antigen B(HEB-29), CF488A conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood group antigen B(HEB-29), CF405M conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood group antigen B(HEB-29), CF405M conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood group antigen B(HEB-29), CF405S conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood group antigen B(HEB-29), CF405S conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood group antigen B(HEB-29), CF640R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood group antigen B(HEB-29), CF640R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood group antigen B(HEB-29), Biotin conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood group antigen B(HEB-29), Biotin conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood group antigen B(HEB-29), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood group antigen B(HEB-29), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood group antigen B(HEB-29), APC conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood group antigen B(HEB-29), RPE conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood group antigen B(HEB-29), PerCP conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood group antigen B(HEB-29), 1mg/mL

Description: Primary antibody against Blood group antigen B(HEB-29), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood group antigen B(HEB-29), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood group antigen B(HEB-29), Concentration: 0.2mg/mL

Description: Primary antibody against Blood group antigen B(HEB-29), Concentration: 0.2mg/mL

Description: Primary antibody against Blood group antigen B(HEB-29), CF660R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood group antigen B(HEB-29), CF660R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood group antigen B(HEB-29), CF555 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood group antigen B(HEB-29), CF555 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood group antigen B(HEB-29), CF543 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood group antigen B(HEB-29), CF543 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood group antigen B(HEB-29), CF568 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood group antigen B(HEB-29), CF568 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood group antigen B(HEB-29), CF647 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood group antigen B(HEB-29), CF647 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), CF594 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), CF594 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), CF680 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), CF680 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), CF680R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), CF680R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), CF770 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), CF770 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), CF488A conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), CF488A conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), CF405M conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), CF405M conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), CF405S conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), CF405S conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), CF640R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), CF640R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), Biotin conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), Biotin conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), APC conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), RPE conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), PerCP conjugate, Concentration: 0.1mg/mL